MATINAS BIOPHARMA HOLDINGS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $11.81 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2024-03-27
- 2023-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $11.81M.
- 2023-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $5.94M.
- 2023-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $12.27M.
- 2022-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $13.24M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2023-09-30 | $11.81M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.94M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $12.27M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $13.24M 10-K · filed 2024-03-27 |
| 2022-09-30 | $10.35M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $15.32M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $5.25M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $8.26M 10-K · filed 2023-03-15 |
| 2021-09-30 | $13.80M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $21.85M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $28.82M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $31.44M 10-K/A · filed 2022-03-11 |
| 2020-09-30 | $33.55K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $29.33K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $22.97K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.00M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |